Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-27 Sale | 2023-01-30 4:32 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 2,000 | $12 | $24,001 | 163,835 (Direct) | View |
| 2023-01-09 Sale | 2023-01-10 4:40 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 2,410 | $15.02 | $36,196 | 165,835 (Direct) | View |
| 2022-12-30 Sale | 2023-01-03 4:32 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 5,200 | $13.45 | $69,932 | 15,516 (Direct) | View |
| 2022-12-27 Sale | 2022-12-29 4:51 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 14,590 | $15.02 | $219,119 | 168,245 (Direct) | View |
| 2022-12-08 Sale | 2022-12-12 4:36 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,550 | $18.95 | $86,238 | 117,456 (Direct) | View |
| 2022-12-02 Sale | 2022-12-06 5:02 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 3,110 | $18.19 | $56,559 | 227,703 (Direct) | View |
| 2022-11-28 Sale | 2022-11-30 4:31 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 2,000 | $13.91 | $27,826 | 182,835 (Direct) | View |
| 2022-11-16 Sale | 2022-11-18 4:59 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 200 | $18.1 | $3,620 | 125,116 (Direct) | View |
| 2022-10-31 Sale | 2022-11-02 4:54 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 2,100 | $24.05 | $50,495 | 45,283 (Direct) | View |
| 2022-10-25 Sale | 2022-10-27 6:49 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 13,000 | $21.27 | $276,549 | 255,120 (Direct) | View |
| 2022-10-25 Sale | 2022-10-27 6:48 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 9,348 | $20.77 | $194,191 | 47,383 (Direct) | View |
| 2022-10-25 Sale | 2022-10-27 6:46 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 14,061 | $20.8 | $292,512 | 184,835 (Direct) | View |
| 2022-10-20 Sale | 2022-10-24 5:13 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 6,080 | $18.66 | $113,426 | 56,731 (Direct) | View |
| 2022-10-20 Sale | 2022-10-24 5:10 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 5,939 | $18.64 | $110,713 | 198,896 (Direct) | View |
| 2022-09-26 Sale | 2022-09-28 5:12 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 10,587 | $15.25 | $161,442 | 204,835 (Direct) | View |
| 2022-09-26 Sale | 2022-09-28 5:10 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 8,593 | $15.29 | $131,428 | 77,459 (Direct) | View |
| 2022-09-26 Sale | 2022-09-28 5:08 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 1,544 | $15.45 | $23,854 | 62,811 (Direct) | View |
| 2022-09-21 Sale | 2022-09-23 4:59 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 4,425 | $15.1 | $66,838 | 215,422 (Direct) | View |
| 2022-09-21 Sale | 2022-09-23 4:57 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 4,280 | $15.08 | $64,560 | 70,905 (Direct) | View |
| 2022-09-21 Sale | 2022-09-23 4:55 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 4,293 | $15.11 | $64,878 | 64,355 (Direct) | View |
| 2022-09-15 Sale | 2022-09-19 4:35 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 200 | $15.04 | $3,008 | 219,847 (Direct) | View |
| 2022-09-15 Sale | 2022-09-19 4:34 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 100 | $15.01 | $1,501 | 68,648 (Direct) | View |
| 2022-09-15 Sale | 2022-09-19 4:32 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 106 | $15.01 | $1,591 | 49,621 (Direct) | View |
| 2022-09-08 Sale | 2022-09-12 4:21 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,788 | $15.12 | $27,039 | 220,047 (Direct) | View |
| 2022-09-08 Sale | 2022-09-12 4:18 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 2,021 | $15.11 | $30,531 | 79,538 (Direct) | View |
| 2022-09-08 Sale | 2022-09-12 4:14 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 1,777 | $15.11 | $26,845 | 68,748 (Direct) | View |
| 2022-08-29 Sale | 2022-08-31 4:55 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 2,000 | $12.72 | $25,435 | 206,710 (Direct) | View |
| 2022-08-24 Sale | 2022-08-26 4:06 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,669 | $13.78 | $64,362 | 119,793 (Direct) | View |
| 2022-08-19 Sale | 2022-08-23 6:28 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 11,655 | $13.08 | $152,432 | 347,233 (Direct) | View |
| 2022-08-16 Sale | 2022-08-18 6:53 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 600 | $13.02 | $7,814 | 368,209 (Direct) | View |
| 2022-07-27 Sale | 2022-07-29 4:03 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 2,000 | $12 | $24,000 | 208,710 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-08 Exercise | 2022-12-12 4:36 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,550 | $2.1 | 117,456 (Direct) | View |
| 2022-12-08 Exercise | 2022-12-12 4:36 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,550 | $0 | 117,456 (Direct) | View |
| 2022-12-02 Exercise | 2022-12-06 5:02 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 3,110 | $2.1 | 227,703 (Direct) | View |
| 2022-12-02 Exercise | 2022-12-06 5:02 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 3,110 | $0 | 227,703 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-18 4:59 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 200 | $2.1 | 125,116 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-18 4:59 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 200 | $0 | 125,116 (Direct) | View |
| 2022-10-25 Exercise | 2022-10-27 6:49 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 13,000 | $2.1 | 255,120 (Direct) | View |
| 2022-10-25 Exercise | 2022-10-27 6:49 pm | N/A 2030-12-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 13,000 | $0 | 255,120 (Direct) | View |
| 2022-09-26 Exercise | 2022-09-28 5:10 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 8,593 | $2.1 | 77,459 (Direct) | View |
| 2022-09-26 Exercise | 2022-09-28 5:10 pm | N/A 2030-12-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 8,593 | $0 | 77,459 (Direct) | View |
| 2022-09-21 Exercise | 2022-09-23 4:57 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 4,280 | $2.1 | 70,905 (Direct) | View |
| 2022-09-21 Exercise | 2022-09-23 4:57 pm | N/A 2030-12-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 4,280 | $0 | 70,905 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-19 4:32 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 106 | $2.1 | 49,621 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-19 4:32 pm | N/A 2030-12-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 106 | $0 | 49,621 (Direct) | View |
| 2022-09-08 Exercise | 2022-09-12 4:18 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 2,021 | $2.1 | 79,538 (Direct) | View |
| 2022-09-08 Exercise | 2022-09-12 4:18 pm | N/A 2030-12-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 2,021 | $0 | 79,538 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:34 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 5,503 | $0 | 16,489 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 5,794 | $0 | 162,144 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:32 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 5,172 | $0 | 20,716 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:32 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 5,632 | $0 | 70,525 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:31 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 15,125 | $0 | 221,835 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 4:06 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,117 | $2.1 | 119,793 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 4:06 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,117 | $0 | 119,793 (Direct) | View |
| 2022-08-19 Exercise | 2022-08-23 6:28 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 5,972 | $2.1 | 347,233 (Direct) | View |
| 2022-08-19 Exercise | 2022-08-23 6:28 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 5,972 | $0 | 347,233 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-18 6:53 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 300 | $2.1 | 368,209 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-18 6:53 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 300 | $0 | 368,209 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:20 pm | N/A 2032-07-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 33,019 | $0 | 33,019 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:19 pm | N/A 2032-07-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 31,032 | $0 | 31,032 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:18 pm | N/A 2032-07-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 33,788 | $0 | 33,788 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:16 pm | N/A 2032-07-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 34,763 | $0 | 34,763 (Direct) | View |